In the BioHarmony Drug Report Database

"Preview" Icon

Asparaginase

Elspar, Spectrila (asparaginase) is an enzyme pharmaceutical. Asparaginase was first approved as Elspar on 1978-01-10. It is used to treat cholelithiasis, lymphoma, and precursor cell lymphoblastic leukemia-lymphoma in the USA. It has been approved in Europe to treat precursor cell lymphoblastic leukemia-lymphoma.

 

Trade Name

 

Spectrila
 

Common Name

 

asparaginase
 

ChEMBL ID

 

CHEMBL2108989
 

Indication

 

cholelithiasis, lymphoma, precursor cell lymphoblastic leukemia-lymphoma
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Asparaginase structure rendering